Lebenthal Global Advisors’s AbbVie ABBV Stock Holding History

Lebenthal Global Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$888K	Sell	3,529 -215	-6%	-$46.3K	0.12%	127
2026 Q1	$814K	Buy	3,744 +1,096	+41%	+$243K	0.12%	128
2025 Q4	$605K	Buy	2,648 +139	+6%	+$31.7K	0.09%	135
2025 Q3	$581K	Buy	2,509 +55	+2%	+$11.2K	0.1%	137
2025 Q2	$456K	Buy	2,454 +724	+42%	+$135K	0.09%	142
2025 Q1	$362K	Hold	1,730	–	–	0.07%	155
2024 Q4	$307K	Hold	1,730	–	–	0.06%	179
2024 Q3	$342K	Hold	1,730	–	–	0.07%	153
2024 Q2	$297K	Hold	1,730	–	–	0.07%	155
2024 Q1	$315K	Hold	1,730	–	–	0.07%	154
2023 Q4	$268K	Hold	1,730	–	–	0.06%	166
2023 Q3	$258K	Hold	1,730	–	–	0.08%	112
2023 Q2	$233K	Hold	1,730	–	–	0.07%	110
2023 Q1	$276K	Hold	1,730	–	–	0.08%	99
2022 Q4	$280K	Hold	1,730	–	–	0.09%	112
2022 Q3	$232K	Sell	1,730 -1,315	-43%	-$189K	0.11%	103
2022 Q2	$465K	Sell	3,045 -4,656	-60%	-$711K	0.23%	72
2022 Q1	$1.25M	Buy	7,701 +501	+7%	+$72.8K	0.53%	28
2021 Q4	$974K	Sell	7,200 -3,599	-33%	-$425K	0.39%	29
2021 Q3	$1.16M	Buy	10,799 +1,315	+14%	+$150K	0.73%	19
2021 Q2	$1.07M	Buy	9,484 +6,716	+243%	+$756K	0.57%	23
2021 Q1	$299K	Sell	2,768 -188	-6%	-$20.1K	0.18%	98
2020 Q4	$316K	Buy	+2,956	New	+$284K	0.22%	61

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lebenthal Global Advisors's ABBV Position: Q2 2026 in Review

Lebenthal Global Advisors reduced its AbbVie (ABBV) stake by 5.7% in Q2 2026, selling an estimated $46.3K and leaving 3,529 shares worth $888K. The position accounts for 0.12% of the portfolio, ranked #127.

Lebenthal Global Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.25M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lebenthal Global Advisors held 3,529 shares of AbbVie worth $888K as of Q2 2026.
Lebenthal Global Advisors sold 215 AbbVie shares in Q2 2026, an estimated $46.3K.
AbbVie made up 0.12% of Lebenthal Global Advisors's portfolio in Q2 2026, its #127 holding.
Lebenthal Global Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
Lebenthal Global Advisors's AbbVie position peaked at $1.25M in Q1 2022.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lebenthal Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.